COVID-19 and Guillain-Barre syndrome: A single-center prospective case series with a 1-year follow-up.

ABSTRACT: Single reports of Guillain-Barré syndrome (GBS) have been reported worldwide during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. While case reports are likely to be biased toward uncommon clinical presentations, systematic assessment of prospective series can highlight the true clinical features and spectrum. In this prospective, observational study, we included all consecutive patients who developed GBS. In patients with SARS-CoV-2 infection as antecedent, the time-gap between the infection and GBS onset had to be ≤30 days. The referral was a neurological University Research Hospital, in the Italian Region more severely involved by the pandemic, and hospitalizing both COVID+ and non-COVID neurological diseases. Clinical, laboratory, cerebrospinal fluid, and e

SUBMITTER: Ahmad L 

PROVIDER: S-EPMC9333081 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature